首页> Journal of pediatric endocrinology & metabolism : JPEM> Mineralocorticoid receptor antagonist monotherapy in pediatric non-classical 11β-hydroxylase deficiency.

Mineralocorticoid receptor antagonist monotherapy in pediatric non-classical 11β-hydroxylase deficiency.

导出 LinkOut

翻译打印收藏纠错

第一作者： Elaine C,Kennedy

第一单位： INFANT Research Centre, University College Cork, Cork, Ireland.;Department of Paediatrics and Child Health, Cork University Hospital, Cork, Ireland.

作者： Elaine C,Kennedy ^[1] ; Maria,Stack ^[2] ; Eirin,Carolan ^[3] ; Maeve,Durkan ^[4] ; Caroline M,Joyce ^[5] ; Colin P,Hawkes ^[6]

作者单位： INFANT Research Centre, University College Cork, Cork, Ireland.;Department of Paediatrics and Child Health, Cork University Hospital, Cork, Ireland. ^[1] Department of Nephrology, Children's Health Ireland at Temple Street, Dublin, Ireland. ^[2] Department of Endocrinology, Children's Health Ireland at Temple Street, Dublin, Ireland. ^[3] Department of Endocrinology, Bon Secours Hospital, Cork, Ireland. ^[4] INFANT Research Centre, University College Cork, Cork, Ireland.;Department of Biochemistry, Cork University Hospital, Cork, Ireland. ^[5] INFANT Research Centre, University College Cork, Cork, Ireland.;Department of Paediatrics and Child Health, Cork University Hospital, Cork, Ireland.;Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. ^[6]

关键词 11 beta-hydroxylase deficiency 11-deoxycortisol congenital adrenal hyperplasia eplerenone

医学主题词人类(Humans);肾上腺增生, 先天性(Adrenal Hyperplasia, Congenital);男(雄)性(Male);青少年(Adolescent);高血压(Hypertension);预后(Prognosis);类固醇11-β-羟化酶(Steroid 11-beta-Hydroxylase)

DOI 10.1515/jpem-2024-0194

PMID 39295130

发布时间 2024-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交